Potential Therapeutic Benefit of Combining Gefitinib and Tamoxifen for Treating Advanced Lung Adenocarcinoma
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Potential Therapeutic Benefit of Combining Gefitinib and Tamoxifen for Treating Advanced Lung Adenocarcinoma
Authors
Keywords
-
Journal
Biomed Research International
Volume 2015, Issue -, Pages 1-11
Publisher
Hindawi Limited
Online
2015-01-27
DOI
10.1155/2015/642041
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combination therapy with anti-ErbB3 monoclonal antibodies and EGFR TKIs potently inhibits Non-small Cell Lung Cancer
- (2015) Alessia Noto et al. Oncotarget
- Targeting Estrogen Receptor- for the Prevention of Nonmelanoma Skin Cancer
- (2014) P.-L. Yao et al. Cancer Prevention Research
- Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis
- (2014) Wen-Lung Ma et al. ENDOCRINE-RELATED CANCER
- Fulvestrant increases gefitinib sensitivity in non-small cell lung cancer cells by upregulating let-7c expression
- (2013) Hua Shen et al. BIOMEDICINE & PHARMACOTHERAPY
- Non-Genomic Estrogen/Estrogen Receptor α Promotes Cellular Malignancy of Immature Ovarian Teratoma In Vitro
- (2013) Yao-Ching Hung et al. JOURNAL OF CELLULAR PHYSIOLOGY
- MicroRNA-21 promotes the ovarian teratocarcinoma PA1 cell line by sustaining cancer stem/progenitor populations in vitro
- (2013) Wei-Min Chung et al. Stem Cell Research & Therapy
- Estrogen receptor beta interacts and colocalizes with HADHB in mitochondria
- (2012) Zhenqi Zhou et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Combine therapy of gefitinib and fulvestrant enhances antitumor effects on NSCLC cell lines with acquired resistance to gefitinib
- (2012) Ruitong Xu et al. BIOMEDICINE & PHARMACOTHERAPY
- Cancer treatment and survivorship statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Role of Hormone Receptor Expression in Patients With Advanced-Stage Lung Cancer Treated With Chemotherapy
- (2012) Valentina Monica et al. Clinical Lung Cancer
- Estrogen Receptor Beta in Cancer: an Attractive Target for Therapy
- (2012) Daniela Gallo et al. CURRENT PHARMACEUTICAL DESIGN
- The transcriptional landscape and mutational profile of lung adenocarcinoma
- (2012) J.-S. Seo et al. GENOME RESEARCH
- Pretreatment Epidermal Growth Factor Receptor (EGFR) T790M Mutation Predicts Shorter EGFR Tyrosine Kinase Inhibitor Response Duration in Patients With Non–Small-Cell Lung Cancer
- (2012) Kang-Yi Su et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical modes of EGFR tyrosine kinase inhibitor failure and subsequent management in advanced non-small cell lung cancer
- (2012) Jin-Ji Yang et al. LUNG CANCER
- Tamoxifen regulates cell fate through mitochondrial estrogen receptor beta in breast cancer
- (2012) M Razandi et al. ONCOGENE
- Differential Role of Estrogen Receptor Beta in Early Versus Metastatic Non-small Cell Lung Cancer
- (2012) Sri Navaratnam et al. Hormones & Cancer
- Estrogen Signaling in Lung Cancer: An Opportunity for Novel Therapy
- (2012) Christina S. Baik et al. Cancers
- The prognostic impact of tumor cell expression of estrogen receptor-α, progesterone receptor, and androgen receptor in patients irradiated for nonsmall cell lung cancer
- (2011) Dirk Rades et al. CANCER
- Lapatinib Activity in Premalignant Lesions and HER-2-Positive Cancer of the Breast in a Randomized, Placebo-Controlled Presurgical Trial
- (2011) A. DeCensi et al. Cancer Prevention Research
- Clinical Significance of Thyroid Transcription Factor-1 in Advanced Lung Adenocarcinoma Under Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment
- (2011) Kuei-Pin Chung et al. CHEST
- Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)
- (2011) Masahiro Fukuoka et al. JOURNAL OF CLINICAL ONCOLOGY
- Characteristics of lung cancer in women: Importance of hormonal and growth factors
- (2011) Isabelle Rouquette et al. LUNG CANCER
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
- (2010) M. Elizabeth H. Hammond et al. JOURNAL OF CLINICAL ONCOLOGY
- Correlation between Epidermal Growth Factor Receptor Mutations and Expression of Female Hormone Receptors in East-Asian Lung Adenocarcinomas
- (2010) Chee-Keong Toh et al. Journal of Thoracic Oncology
- Expression of estrogen receptor beta predicts a clinical response and longer progression-free survival after treatment with EGFR–TKI for adenocarcinoma of the lung
- (2010) Naohiro Nose et al. LUNG CANCER
- Gender Disparity of Hepatocellular Carcinoma: The Roles of Sex Hormones
- (2010) Shiou-Hwei Yeh et al. ONCOLOGY
- Estrogen receptor beta (ERβ) subtype-specific ligands increase transcription, p44/p42 mitogen activated protein kinase (MAPK) activation and growth in human non-small cell lung cancer cells
- (2009) Pamela A. Hershberger et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer
- (2009) Rafael Rosell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
- (2009) Tony S. Mok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Estrogen Receptor Signaling in Lung Cancer
- (2009) Jill M. Siegfried et al. SEMINARS IN ONCOLOGY
- Association Between Estrogen Receptor-β Expression and Epidermal Growth Factor Receptor Mutation in the Postoperative Prognosis of Adenocarcinoma of the Lung
- (2008) Naohiro Nose et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search